$CORT

Corcept Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$23.37 β–Ό-1.392%

Delayed Price

VOLUME

314,234

DAY RANGE

-

52 WEEK

19.19 - 34.28

Join Discuss about CORT with like-minded investors

profile
@dros #droscrew
recently

Top Earnings Wed 5/3 Aft: $ACEL $ACLS $ACR $ACT $ADPT $AEIS $ALB $ALKT $ALL $ALLO $AMED $AMK $AMOT $AMPY $AMWL $ANSS $APA $ARC $ARDX $ASPN $ATO $ATUS $AUR $AVNW $AVT $BBSI $BCOV $BHE $BKH $BNL $CCRN $CDAY $CENT $CENTA $CFLT $CHRD $CIVI $CLMB $CMPO $CODI $COKE (1/6) Top Earnings Wed 5/3 Aft: $CORT $CPE $CPK $CPS $CRD/A $CSGS $CSTL $CSV $CTSH $CTVA $CW $CXW $DEN $DHT $DLHC $DRS $ECOR $ECPG $ELA $EQC $EQH $EQIX $ERII $ES $ESTE $ETSY $EVH $EZPW $FARO $FATE $FBRT $FG $FLT $FNF $FORM $FPI $FROG $FSLY $GHL $GIL $GKOS $GL $GMRE $GNK (2/6) Top Earnings Wed 5/3 Aft: $GNW $GOOD $GRBK $GTBIF $HBB $HCC $HDSN $HOUS $HST $HUBS $INFA $INFN $INMB $INN $INSG $IOSP $IPI $IR $IVAC $JOBY $KLIC $KNTK $KTOS $KW $LESL $LMND $LODE $LUMO $MELI $MET $METC $MG $MGY $MKSI $MLR $MMS $MOR $MOS $MRAM $MRO $MTG $MX $MYGN (3/6) Top Earnings Wed 5/3 Aft: $NARI $NC $NE $NFG $NGVT $NSTG $NUS $NVEC $NVST $NWPX $NYMT $O $OLED $OM $OPAD $OPK $OUT $PAHC $PARR $PCOR $PDCE $PGRE $PKOH $PLMR $PSA $PSNL $QCOM $QDEL $QGEN $QNST $QRVO $RDN $REI $RELY $REZI $RGLD $RGNX $RGR $RHP $RM $RMNI $RMR $ROOT (4/6) Top Earnings Wed 5/3 Aft: $RPT $RSI $RUN $RVLV $RYN $SBOW $SBRA $SEDG $SGU $SIGI $SITM $SNEX $SP $SPNT $SPOK $SRC $SRI $SRTS $STAA $STR $SUM $SYNA $TIPT $TNDM $TPIC $TPL $TPVG $TRIP $TSVT $TTEC $TTMI $TWI $TXG (5/6) Top Earnings Wed 5/3 Aft: $UDMY $UFI $UGI $ULCC $UPWK $USDP $USIO $USPH $VAC $VAPO $VET $VMEO $VNDA $VSTO $VTOL $WEAV $WERN $WES $WMB $WTS $YELL $Z $ZG $ZIMV (6/6)

101 Replies 8 πŸ‘ 10 πŸ”₯

profile
@dros #droscrew
recently

Upgrades 8/1: $CFR $CL $ES $LTC $PAA $PAGP $TGT . Downgrades 8/1: $ABBV $AEO $BMBL $CE $CHTR $CMCSA $CORT $DECK $EMN $ESRT $FBNC $FCPT $LCII $LYB $MHK $PAA $POR $PUBM $RARE $REI $SFST $SWK $TBLA $VOD $WEBR

141 Replies 13 πŸ‘ 14 πŸ”₯

profile
@dros #droscrew
recently

+Initiations 6/27: $ACM $AXTI $BLBX $CORT $DRI $ENOV $GROV $IFF $LQDT $ML $RPM $SIGI $TXRH . -Initiations 6/27: $ALB $BPMC $CE $EAT $LYB $ORCL

109 Replies 15 πŸ‘ 10 πŸ”₯

profile
@dros #droscrew
recently

Unusually active option classes on open December 16th $BEKE $CORT $KGC $VRM $UPS $T $NVAX $SHOP $BKKT $NVDA

104 Replies 7 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$CORT green

125 Replies 10 πŸ‘ 10 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

stabbed some ss on $CORT here

133 Replies 7 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

wow $CORT picking up steam

49 Replies 13 πŸ‘ 15 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$CORT 20.50's will be interesting

144 Replies 15 πŸ‘ 8 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

Possible first red days: $GOGO, $SHLL, $CORT, $FEAC, $FMCI

91 Replies 7 πŸ‘ 10 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

congrats to $CORT ss

143 Replies 7 πŸ‘ 10 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

taking $CORT long here 19.70

70 Replies 7 πŸ‘ 14 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

wow $CORT today

118 Replies 15 πŸ‘ 10 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$CORT 88M Float!? hmmm

137 Replies 10 πŸ‘ 14 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

whats up with $CORT ? not seeing anything on it

146 Replies 10 πŸ‘ 10 πŸ”₯

SJ
@sj2343 #StockTraders.NET
recently

long CORT for rip into close

131 Replies 10 πŸ‘ 11 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

I wouldn’t even short CORT here

57 Replies 13 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

shorting weakness on CORT is how it traps shorts

78 Replies 11 πŸ‘ 15 πŸ”₯

profile
@DHouse #StockTraders.NET
recently

CORT had big calls coming in at 19, 20 level, majority institutionally owned, very high float yet up 100%... so that was my confirmation not to enter , or if i did, be supremely nimble

52 Replies 14 πŸ‘ 7 πŸ”₯

profile
@FillTheGapToZero #StockTraders.NET
recently

anyone see $CORT

105 Replies 11 πŸ‘ 10 πŸ”₯

profile
@viking #StockTraders.NET
recently

whats the news on $CORT anyway

122 Replies 14 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

glad I covered most on $CORT

97 Replies 8 πŸ‘ 7 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

there goes CORT

97 Replies 6 πŸ‘ 15 πŸ”₯

profile
@Math #StockTraders.NET
recently

covered 1/2 CORT low 18s

135 Replies 9 πŸ‘ 8 πŸ”₯

AN
@andres168 #StockTraders.NET
recently

Cov some $cort

99 Replies 12 πŸ‘ 6 πŸ”₯

profile
@DHouse #StockTraders.NET
recently

96 Replies 15 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

only got 500 shares left in $CORT

81 Replies 11 πŸ‘ 15 πŸ”₯

profile
@DHouse #StockTraders.NET
recently

dont understand CORT at all

52 Replies 11 πŸ‘ 8 πŸ”₯

profile
@dros #droscrew
recently

Largest Call/Put Ratio: $CORT

68 Replies 13 πŸ‘ 11 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

uoa $CORT 18C Sept

79 Replies 8 πŸ‘ 12 πŸ”₯

profile
@Benlax #droscrew
recently

$ASND At $5.5B EV ( $1B in cash) this is compelling risk / reward with big upside from these levels imo. Had to free some cash. Sold out $CORT due to not as high conviction (Teva lawsuit bothers me lol) plus profit is profit. Summary: -Derisked gHD (growth hormone deficiency) best in class ONCE-WEEKLY therapy. Standard of care currenttly are daily injections of hGH. - Based on P2 data de-risked to great extent HP (hypoparathyroidism) PTH compound. Potentially superior over Natpara that's currently recalled by FDA. Patients desperately need new therapies here. > $1B on peak rev potential. raps.org/news-and-articles/... - Transcon CNP in P2 trial for Achondroplasia. Currently there are NO any FDA-approved treatments to address this most common type of dwarfism. - Move into Oncology therapeutic area based on Vision 3x3 strategic roadmap. 3rd therapeutic area for TransCon TBD

99 Replies 12 πŸ‘ 13 πŸ”₯

Key Metrics

Market Cap

2.45 B

Beta

0.80

Avg. Volume

1.41 M

Shares Outstanding

103.52 M

Yield

0%

Public Float

0

Next Earnings Date

2024-05-01

Next Dividend Date

Company Information

leading the field in the discovery of drugs that modulate the effects of cortisol the adverse effects of excess cortisol have been corcept’s focus since the company’s inception. abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol. in addition to our work with mifepristone, we have developed over 300 proprietary molecules, advancing the most promising of these to the clinic to see if they can mitigate the effects of excess cortisol and the serious, sometimes life-threatening conditions that may result. all of these compounds competitively block the glucocorticoid receptor (gr), but not the progesterone receptor. scientific literature suggests that competitive gr antagonism may have a role in treating many conditions, including post-traumatic stress disorder, mild cognitive impairment, alzheimer’s disease, alcoholis

CEO: Joseph Belanoff

Website:

HQ: 149 Commonwealth Dr Menlo Park, 94025-1133 California

Related News